(Q77597680)
Statements
VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (protocol MY 85) (English)
P Mineur
J F Ménard
X Le Loët
J F Bernard
B Grosbois
J P Pollet
I Azais
J P Laporte
C Doyen
A De Gramont
M Wetterwald
L Euller-Ziegler
A M Peny
M Monconduit
1 November 1998